Michelle Esophageal Cancer |  Diagnosed 2016

"They need me to be the rock, and I can be the rock because I did that trial."

Michelle 's Story

Originally diagnosed in July 2016, Michelle’s treatment plan progressed very quickly, including chemotherapy, radiation therapy, and surgery. Her family and coworkers helped support her throughout treatment. Declared cancer-free by the end of December 2016, she considered her next steps to stay cancer-free. In February 2017, she met with Dr. Deirdre Cohen at at NYU Langone’s Perlmutter Cancer Center, who recommended Michelle enroll in a clinical trial of nivolumab (Opdivo®). Over a year later, Michelle remains cancer-free and can plan new adventures with her husband and daughter.

 

We're Stronger Together

Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.

Share Your Story
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

Patient education information supported by a charitable donation from Bristol-Myers Squibb Company.
Top